JD Health International Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a JDHIY research report →
About the company
JD Health International Inc. , an investment holding firm, oversees an internet-based healthcare platform across the People's Republic of China. The company supplies a comprehensive range of pharmaceutical and health-related products, including over-the-counter and prescription medications, various medical equipment and supplies, along with health supplements and restorative tonics.
- CEO
- Cao Dong
- IPO
- 2022
- Employees
- 3,564
- HQ
- Beijing, CN
Price Chart
- Market Cap
- $14.93B
- P/E
- 18.55
- P/S
- 1.36
- P/B
- 1.66
- EV/EBITDA
- 17.38
- Div Yield
- 0.00%
- Gross Margin
- 24.78%
- Op Margin
- 5.17%
- Net Margin
- 7.32%
- ROE
- 9.11%
- ROIC
- 5.53%
- Revenue
- $71.44B · 22.83%
- Net Income
- $5.23B · 25.64%
- EPS
- $1.68 · 27.27%
- Op Income
- $3.69B
- FCF YoY
- 133.85%
- 52W High
- $9.08
- 52W Low
- $4.26
- 50D MA
- $5.82
- 200D MA
- $7.93
- Beta
- 1.15
- Avg Volume
- 143
Get TickerSpark's AI analysis on JDHIY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our JDHIY coverage
Recent articles, reports, and earnings notes.
No research on JDHIY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate JDHIY report →Similar companies
Peers in the same neighborhood.